A Rac–Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells
Open Access
- 16 August 2010
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 29 (43) , 5839-5849
Abstract
The activation of receptor tyrosine kinases, particularly ErbB2, has an important role in the genesis of breast cancer. ErbB2 kinase activity promotes Ras-mediated stimulation of downstream protein kinase cascades, including the Ras/Raf-1/MAPK/ERK kinase (Mek)/extracellular signal-regulated kinase (Erk) pathway, leading to tumor cell growth and migration. Signaling through the Ras–Erk pathway can be influenced by p21-activated kinase-1 (Pak1), an effector of the Rho family GTPases Rac and Cdc42. In this study, we asked if ErbB2 expression correlates with Pak1 and Erk activity in human breast cancer specimens, and if Pak1 signaling is required for ErbB2 transformation in a three-dimensional (3D) in vitro setting and in xenografts. We found a correlation between ErbB2 expression and activation of Pak in estrogen receptor-positive human breast tumor samples and observed that in 3D cultures, activation of Rac–Pak1 pathway by ErbB2 homodimers induced growth factor-independent proliferation and promoted disruption of 3D mammary acinar-like structures through activation of the Erk and Akt pathways. Further, we found that inhibition of Pak1 by small molecules compromised activation of Erk and Akt, resulting in reversion of the malignant phenotype and restoration of normal acinar architecture. Finally, ErbB2-amplified breast cancer cells expressing a specific Pak inhibitor showed delayed tumor formation and downregulation of Erk and Akt signaling in vivo. These data imply that the Rac–Pak pathway is vital to ErbB2-mediated transformation and that Pak inhibitors represent plausible drug targets in breast cancers in which ErbB2 signaling is activated.Keywords
This publication has 36 references indexed in Scilit:
- An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalentlyMolecular Cancer Therapeutics, 2009
- HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironmentBreast Cancer Research and Treatment, 2009
- Interaction with LC8 Is Required for Pak1 Nuclear Import and Is Indispensable for Zebrafish DevelopmentPLOS ONE, 2009
- Pak protein kinases and their role in cancerCancer and Metastasis Reviews, 2009
- Targeting Large Kinase Active Site with Rigid, Bulky Octahedral Ruthenium ComplexesJournal of the American Chemical Society, 2008
- Scaffolding function of PAK in the PDK1–Akt pathwayNature Cell Biology, 2008
- Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytesJournal of Molecular and Cellular Cardiology, 2008
- Nuclear p21-Activated Kinase 1 in Breast Cancer Packs Off Tamoxifen SensitivityCancer Research, 2006
- PAK1 hyperactivation is sufficient for mammary gland tumor formationOncogene, 2005
- Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1bOncogene, 2000